BC Environmental and Occupational Health Research Network

The CIHR HIV/AIDS Community-Based Research (CBR) Program assists community-based organizations, non-governmental organizations and institutions in developing the knowledge necessary to carry out their HIV/AIDS work in the most effective manner, and in creating expertise within these communities to conduct their own research. The aim of this Catalyst Grant is to provide seed money, on a short-term basis, to support health research activities which represent a first step towards the pursuit of more comprehensive funding opportunities (e.g., operating grants).

The CIHR Program Grant in Transplantation Research has been developed in response to the workshop recommendations and will provide an opportunity for the transplantation community to come together in a national Program that will transform the clinical outcomes for Canadian transplant patients. The Program will integrate independently-fundable research projects and may include core technologies. The Program will encompass a number of sub-projects addressing the many facets of solid organ and HSCT transplantation, including research focused on, but not limited to, the priority areas described below. The Program will unite researchers from at least three of the four health research themes: biomedical; clinical; health systems and services; and population and public health and demonstrate a clear advantage over independent, single grants and a strong value-added component over status quo. The sub-projects that make up the Program must represent scientific input from all Principal Applicants. These sub-projects, which may differ substantially in size, complexity and cost, must be able to stand alone as independently-fundable research projects, but at the same time, must contribute substantially to the primary research goals of the program as a whole. Each sub-project can be either single focus or multidisciplinary in composition and scope.

Under the framework of the ICS Program, IPPH will consider requests that:
• fall within the general objectives of this funding program;
• address one or more of the IPPH strategic priorities (listed below);
• increase the capacity of the Canadian health research community to lead and collaborate on cutting-edge population and public health research and knowledge translation, both nationally and internationally;
• build on/align with existing IPPH initiatives (e.g. Applied Public Health Chairs, Strategic Training Initiative in Health Research); and,
• support and accelerate the translation of research on population health interventions and implementation systems into practice, programs, and policies within the health and other sectors.

Applications are sought for knowledge syntheses grants that will underpin the future development of interventions related to suicide prevention. These syntheses should summarize the empirical evidence related to the effectiveness of suicide prevention interventions.
The successful teams will have six months to complete their synthesis at which time the team will present the results of their synthesis to Health Policy makers, research funders, and other stakeholders and will assist the group in the interpretation and contextualization of the findings. Expedited Knowledge Synthesis uses all of the characteristics of a standard CIHR funding opportunity, but several innovations have been introduced to allow a quick response to the knowledge needs of decision makers. As this is a novel program we encourage applicants to review all sections of this funding opportunity carefully.

Through the Betty Havens Prize for Knowledge Translation in Aging, the CIHR-Institute of Aging will recognize individual(s), team(s) or organization(s) that have advanced the translation of research in aging at a local or regional level. The CIHR Knowledge Translation Prize 2012 honours and supports the exemplary knowledge translation efforts and activities of an exceptional individual, team or organization that has made an outstanding contribution to increasing the application of research findings, improving the health of individuals, improving health services and products, or strengthening the health-care system at a national or international level.

Through the Institute Community Support (ICS) Program, the CIHR Institutes are launching the ICS Travel Awards competition for students, postdoctoral fellows, new investigators and knowledge users to present their own research at national and international meetings and/or conferences. This ICS Travel Awards competition will not support travel for research skills development or update, exchange programs or lectureships.

The specific objectives of this funding opportunity are:
• Increase and promote interest in health research and careers in health research among today’s youth across Canada.
• Position CIHR in the minds of Canadians as a national leader in supporting youth health research literacy.
• Establish and maintain collaborative relationships with national science youth outreach stakeholders and service providers in Canada.
• Strengthen CIHR’s value and impact as the Government of Canada’s agency for health research.

This Funding Opportunity invites research teams to submit proposals for the conduct of a combined Phase I/II interventional clinical trial for CCSVI in multiple sclerosis patients. Working with the Scientific Expert Working Group, CIHR has identified select elements (some being very specific) that all applications will be required to incorporate into their proposed trial design. Those specific requirements for inclusion (or exclusion) are outlined as part of the application requirements below.

The Proof of Principle (POP) Phase II Program provides funding for proof of principle research projects up to 12 months in duration at the co-investment stage undertaking follow-on proof of principle activities in partnership with a non-academic investor. This funding opportunity is aimed at providing a platform to better enable the academic institution/researcher to move the discovery/invention further down the innovation pipeline. Research projects across all four pillars of CIHR are eligible for this program. Note that the end product is not required to generate revenue, but there must be a demonstrated market and opportunity for your product.

The specific objective of the Proof of Principle: Phase I Priority Announcement (Specific Research Areas) is to offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas and mandates.

The Proof of Principle (POP) Phase I program provides funding for proof of principle research projects of up to 12 months duration designed to advance discoveries/inventions towards commercializable technologies, with a view to attract new investment, create new science-based businesses, organizations and initiatives, and ultimately improve health outcomes for Canadians. Research projects across all four pillars of CIHR are eligible for this program. Note that the end product is not required to generate revenue, but there must be a demonstrated market and opportunity for your product. Applications for the continuation of a research project funded through the POP Phase I grant must progress from Phase I to Phase II.

The purpose of this program is to further strengthen clinical research by providing research training to health professionals and strengthen talent development. It is expected that this targeted investment will lead to the development of the next generation of clinician-researchers.

The specific objective of the Dissemination Events Priority Announcement (Specific Research Areas) is to offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas and mandates.

The specific objective of this funding opportunity is to support events/activities that contribute to the dissemination, exchange and uptake of research evidence.
Events/activities may focus on, but are not limited to, the following:
- Education of groups such as patients, health professionals, community organizations, policy-makers, the general public;
- Knowledge dissemination that will inform practice, clinical care, partnership best practices, policy and decision making;
- Dissemination and/or discussion of research findings at scientific meetings, workshops, conferences, congresses or symposia.

CIHR’s mandate in ethics involves fostering research in health ethics.
The purpose of this funding opportunity is to build capacity in ethics as it applies to health (including health research, health promotion and maintenance, clinical care, population and public health, health systems and services, policy and governance) by encouraging applications from nominated principal applicants who are new investigators in the field of health ethics, or investigators new to the field of health ethics, by offering one or two-year pilot project grants.

This is a Funding Opportunity inviting research teams to submit proposals for the conduct of a combined Phase I/II interventional clinical trial for CCSVI in multiple sclerosis patients.
Working with the Scientific Expert Working Group, CIHR has identified select elements (some being very specific) that all applications will be required to incorporate into their proposed trial design.

The purpose of this funding opportunity is to provide undergraduate and health professional students with opportunities to undertake research projects with established health researchers in an environment that provides strong mentorship. In addition, the intent of the initiative is to develop human resources and expertise to facilitate the translational research objectives of CIHR (including clinical research). Furthermore, this opportunity targets the early stage of the student’s academic training to encourage the pursuit of research in areas of strategic interest to CIHR’s Institute of Musculoskeletal Health and Arthritis (IMHA) and CIHR’s Institute of Aging (IA).

This "Team Grant: Bone Health" is being offered to encourage and stimulate new and established investigators to undertake new, high priority research challenges in the field of bone health. These bone health teams will focus on at least one of these research priority areas. This competition is open to applications that address issues related to health and disease, health care and the health system.

CIHR’s Science to Business (S2B) program is designed to encourage individuals with PhDs in a health related field to pursue an MBA. It is anticipated that successful applicants to the program will go on to apply their management and scientific expertise by pursuing careers in fields that support commercialization and innovation in Canada such as management, regulatory affairs, finance, research, technology transfer, and public policy. The goal of this program is to develop a cadre of professionals knowledgeable in health research and management, and to foster an entrepreneurial culture within and around the research community.
CIHR’s S2B award is administered separately from MBA admissions processes at business schools and applying for or receiving the S2B scholarship will not necessarily facilitate acceptance into an MBA program.

The CIHR Knowledge Translation Prize honours and supports the exemplary knowledge translation efforts and activities of an exceptional individual, team, or organization that has made an outstanding contribution to increasing the application of research findings, improving the health of individuals, improving health services and products, or strengthening the health-care system.
Nominated individuals, teams or organizations will be assessed on significant achievements in knowledge translation activities relevant to any area of health research (e.g., biomedical, clinical, health services and policy, and population and public health), including that of commercialization and global health.